383 related articles for article (PubMed ID: 21120535)
1. Osteoblast physiology in normal and pathological conditions.
Neve A; Corrado A; Cantatore FP
Cell Tissue Res; 2011 Feb; 343(2):289-302. PubMed ID: 21120535
[TBL] [Abstract][Full Text] [Related]
2. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
[TBL] [Abstract][Full Text] [Related]
3. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC
J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
[TBL] [Abstract][Full Text] [Related]
4. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
[TBL] [Abstract][Full Text] [Related]
5. CCL20 chemokine induces both osteoblast proliferation and osteoclast differentiation: Increased levels of CCL20 are expressed in subchondral bone tissue of rheumatoid arthritis patients.
Lisignoli G; Piacentini A; Cristino S; Grassi F; Cavallo C; Cattini L; Tonnarelli B; Manferdini C; Facchini A
J Cell Physiol; 2007 Mar; 210(3):798-806. PubMed ID: 17133360
[TBL] [Abstract][Full Text] [Related]
6. Receptor Activator for Nuclear Factor kappa B Ligand (RANKL) as an osteoimmune key regulator in bone physiology and pathology.
Narducci P; Bareggi R; Nicolin V
Acta Histochem; 2011 Feb; 113(2):73-81. PubMed ID: 19926120
[TBL] [Abstract][Full Text] [Related]
7. Osteoclast-osteoblast communication.
Matsuo K; Irie N
Arch Biochem Biophys; 2008 May; 473(2):201-9. PubMed ID: 18406338
[TBL] [Abstract][Full Text] [Related]
8. [Osteoblast-osteoclast interaction mechanisms].
Riancho JA; Delgado-Calle J
Reumatol Clin; 2011 Sep; 7 Suppl 2():S1-4. PubMed ID: 21924211
[TBL] [Abstract][Full Text] [Related]
9. IL-1 plays an important role in the bone metabolism under physiological conditions.
Lee YM; Fujikado N; Manaka H; Yasuda H; Iwakura Y
Int Immunol; 2010 Oct; 22(10):805-16. PubMed ID: 20679512
[TBL] [Abstract][Full Text] [Related]
10. [Osteoclast function is regulated by neighbouring osteoblasts. Osteoprotegerin, RAND and RANK ligand constitute a unique regulatory system for bone resorption with important pathophysiological and therapeutic aspects].
Ueland T; Bollerslev J; Mosekilde L
Ugeskr Laeger; 2002 Jul; 164(27):3526-30. PubMed ID: 12116680
[TBL] [Abstract][Full Text] [Related]
11. [Development, physiology, and cell activity of bone].
de Baat P; Heijboer MP; de Baat C
Ned Tijdschr Tandheelkd; 2005 Jul; 112(7):258-63. PubMed ID: 16047964
[TBL] [Abstract][Full Text] [Related]
12. Rheumatic diseases: the effects of inflammation on bone.
Walsh NC; Crotti TN; Goldring SR; Gravallese EM
Immunol Rev; 2005 Dec; 208():228-51. PubMed ID: 16313352
[TBL] [Abstract][Full Text] [Related]
13. Microrough implant surface topographies increase osteogenesis by reducing osteoclast formation and activity.
Lossdörfer S; Schwartz Z; Wang L; Lohmann CH; Turner JD; Wieland M; Cochran DL; Boyan BD
J Biomed Mater Res A; 2004 Sep; 70(3):361-9. PubMed ID: 15293309
[TBL] [Abstract][Full Text] [Related]
14. Biology of the basic multicellular unit and the pathophysiology of osteoporosis.
Jilka RL
Med Pediatr Oncol; 2003 Sep; 41(3):182-5. PubMed ID: 12868116
[TBL] [Abstract][Full Text] [Related]
15. Boning up on ephrin signaling.
Mundy GR; Elefteriou F
Cell; 2006 Aug; 126(3):441-3. PubMed ID: 16901775
[TBL] [Abstract][Full Text] [Related]
16. Intercellular adhesion molecule 1 discriminates functionally different populations of human osteoblasts: characteristic involvement of cell cycle regulators.
Tanaka Y; Maruo A; Fujii K; Nomi M; Nakamura T; Eto S; Minami Y
J Bone Miner Res; 2000 Oct; 15(10):1912-23. PubMed ID: 11028443
[TBL] [Abstract][Full Text] [Related]
17. Osteoblasts and bone formation.
Caetano-Lopes J; Canhão H; Fonseca JE
Acta Reumatol Port; 2007; 32(2):103-10. PubMed ID: 17572649
[TBL] [Abstract][Full Text] [Related]
18. RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis.
Pettit AR; Walsh NC; Manning C; Goldring SR; Gravallese EM
Rheumatology (Oxford); 2006 Sep; 45(9):1068-76. PubMed ID: 16490750
[TBL] [Abstract][Full Text] [Related]
19. Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio.
Seriwatanachai D; Thongchote K; Charoenphandhu N; Pandaranandaka J; Tudpor K; Teerapornpuntakit J; Suthiphongchai T; Krishnamra N
Bone; 2008 Mar; 42(3):535-46. PubMed ID: 18166509
[TBL] [Abstract][Full Text] [Related]
20. CB(2) and TRPV(1) receptors oppositely modulate in vitro human osteoblast activity.
Rossi F; Bellini G; Tortora C; Bernardo ME; Luongo L; Conforti A; Starc N; Manzo I; Nobili B; Locatelli F; Maione S
Pharmacol Res; 2015 Sep; 99():194-201. PubMed ID: 26117426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
